Pancreatic cancer-associated fibroblasts: function, detection, and regulation
胰腺癌相关成纤维细胞:功能、检测和调节
基本信息
- 批准号:10418178
- 负责人:
- 金额:$ 51.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalActin-Binding ProteinActinsAnimal ModelArchivesBindingBiochemicalBiogenesisBiological MarkersBloodBundlingCartoonsCellsClinicalClinical TrialsDataData SetDesmoplasticDetectionDevelopmentECM receptorEndocytosisEquilibriumExhibitsExtracellular MatrixFeedbackFibroblastsFoxesFutureGoalsGrowthHarvestHumanImmune systemIn VitroInflammatoryIntegrin alpha5beta1IntegrinsKnock-outLinkMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of pancreasMeasuresMetabolicMetabolismMethodsMolecularMolecular ConformationMonitorMusNutritionalOutcomePTK2 genePancreatic Ductal AdenocarcinomaPathologicPatientsPeptidesPlasmaPolarization MicroscopyProcessProductionProteinsRegulationReportingRoleRouteSamplingSeriesSignal TransductionStressStromal CellsStructureSupporting CellSystemTestingTissuesTransforming Growth Factor betaWorkanti-cancerantitumor effectbasecancer typedesigneffective therapyextracellularextracellular vesiclesgenetic regulatory proteinimmunoregulationimprovedin vivoinhibitorinterstitialloss of functionmimeticsminimally invasivemouse modelnetrin-G1novelpancreatic cancer cellspancreatic ductal adenocarcinoma cellpancreatic ductal adenocarcinoma modelpancreatic neoplasmpostsynapticpresynapticpreventproteomic signaturereceptorresponsesample archivethree dimensional cell culturetranscriptome sequencingtumor
项目摘要
PROJECT SUMMARY/ABSTRACT
Pancreatic cancer induces a fibrous microenvironment, desmoplasia, which spans most of the tumor mass and
contains cancer-associated fibroblasts (CAFs). CAFs sustain a cancer homeostatic equilibrium by producing
extracellular matrices (ECMs) and secreting inflammatory factors. The ECM produced by CAFs prompts normal
fibroblasts to undergo activation and transition into CAFs, thereby propagating desmoplastic expansion in a
positive feedback loop. While the normal microenvironment suppresses tumor onset, desmoplasia can either
support or avert pancreatic cancer. A better understanding of desmoplastic expansion and the ECM factors that
control it could enable us to favor its anti-cancer functions. In fact, several clinical trials including some conducted
at Fox Chase, aim at “normalizing desmoplasia” with the goal of harnessing CAF’s anti-tumor effects.
Of note, we have defined a signaling axis that depends on CAF-ECM and includes its main receptors, integrins,
and some actin bundling, particular endocytic regulatory proteins, and an extracellularly tethered presynaptic
protein known as NetrinG1. Of note, NetrinG1 necessities co-receptors in cis and in trans to signal and we
revealed that in response to ECM NetrinG1 drives pro-tumor CAF function. We also reported that ECM induced
pro-tumor CAF activation includes the endocytic localization of the active conformation of an important ECM
receptor, activated α5β1-integrin (a-α5), which we posit regulates the production of two unique extracellular
vesicles. Finally, we saw that the trans co-receptor of NetrinG1 is expressed in CAFs and needed for effective
formation of tumors when pancreatic cancer cells are injected into the pancreata of immune system-intact mice.
Our central premise proposes that CAF pro-to-anti tumor function transition can be attained via blockage
of the ECM-dependent NetrinG1 signaling axis, which is needed to achieve the functional “desmoplastic
normalization” that can be detected in blood.
We plan to test this hypothesis in three specific aims:
1- Ask how CAF-ECM regulates NetrinG1 expression and endocytic a-α5 regulation as well as what are the
specific ECM components that are responsible for NetrinG1 expression and CAF’s pro-tumor function.
2- Investigate if the unique extracellular vesicles generated by NetrinG1 expressing CAFs could be traced
systemically in patients’ blood (including archived samples and samples from the ongoing trial) and ask if these
are indicative of the tumor associated desmoplastic pro vs anti-pancreatic cancer statuses.
3- Inquire if NetrinG1’s trans receptor, expressed in pro-tumoral functioning CAFs, could serve as a new target.
The study’s ultimate goal is to capitalize on the natural tumor suppressive function and features of CAFs and
block the tumor promoting ones as well as to systemically induce and detect a pro-to-anti pancreatic cancer CAF
transition, which could be indicative of local desmoplastic status, for potential future clinical uses.
项目摘要/摘要
胰腺癌诱导了纤维微环境,脱木质,该环境涵盖了大多数肿瘤质量和
包含与癌症相关的成纤维细胞(CAF)。 CAF通过产生癌症稳态平衡
细胞外矩阵(ECM)和分泌炎症因素。 CAF生产的ECM提示正常
成纤维细胞会激活并过渡到CAF,从而在A
积极的反馈循环。正常的微环境抑制肿瘤的发作,而脱木质可以
支持或避免胰腺癌。更好地理解脱糖扩展和ECM因素
控制它可以使我们能够偏爱其抗癌功能。实际上,一些临床试验在内
在福克斯·蔡斯(Fox Chase),旨在“使脱木质”归一化,目的是利用CAF的抗肿瘤效应。
值得注意的是,我们定义了一个取决于CAF-ECM的信号轴,并包括其主要受体,整联蛋白,
还有一些肌动蛋白束,特定的内吞调节蛋白和细胞外束缚前突触
蛋白质称为Netring1。值得注意的是,netring1需要顺式和转换中的共受体,我们
揭示了对ECM Netring1的响应,驱动了亲肿瘤CAF的功能。我们还报告了ECM诱导的
亲肿瘤CAF激活包括重要ECM的主动构象的内吞定位
受体,激活的α5β1-整合蛋白(A-α5),我们可以调节两个独特的细胞外产生
囊泡。最后,我们看到netring1的反式共振动器在CAF中表达,需要有效
当将胰腺癌细胞注入免疫系统独立小鼠的胰腺时,肿瘤的形成。
我们的中心前提提出的CAF Pro-Ati肿瘤功能过渡可以通过阻塞附加
依赖ECM的Netring1信号轴的轴,这是实现功能性“脱塑料”所需的
可以在血液中检测到的归一化”。
我们计划以三个具体目标来检验这一假设:
1-询问CAF-ECM如何调节Netring1表达和内吞A-α5调控以及什么是
负责Netring1表达和CAF的促肿瘤功能的特定ECM组件。
2-调查是否可以追溯到由Netring1表达CAF产生的独特细胞外蔬菜
系统地在患者的血液中(包括正在进行的试验中的存档样本和样本),并询问这些是否是否
指示与肿瘤相关的脱肿瘤疾病与抗胰腺癌统计。
3-询问Netring1的trans接收器是否在肿瘤功能CAF中表示,是否可以作为新目标。
该研究的最终目标是利用CAFS的自然肿瘤抑制功能和特征
阻止促进肿瘤的肿瘤,并系统地诱导和检测pro-to-anti胰腺癌CAF
对于潜在的未来临床用途,过渡可能表明局部去肿瘤状态。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edna Cukierman其他文献
Edna Cukierman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edna Cukierman', 18)}}的其他基金
Neutralizing Stromal NetrinG1 to Intercept Pancreatic Cancer
中和基质 NetrinG1 以阻止胰腺癌
- 批准号:
10505615 - 财政年份:2022
- 资助金额:
$ 51.71万 - 项目类别:
Pancreatic Cancer-Associated Fibroblasts: Function, Detection, and Regulation
胰腺癌相关成纤维细胞:功能、检测和调节
- 批准号:
10767490 - 财政年份:2022
- 资助金额:
$ 51.71万 - 项目类别:
Pancreatic cancer-associated fibroblasts: function, detection, and regulation
胰腺癌相关成纤维细胞:功能、检测和调节
- 批准号:
10625325 - 财政年份:2022
- 资助金额:
$ 51.71万 - 项目类别:
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin
黑色素瘤转移和治疗耐药性的综合方法:ECM 和皮肤生物力学与年龄相关变化的影响
- 批准号:
10380313 - 财政年份:2021
- 资助金额:
$ 51.71万 - 项目类别:
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin
黑色素瘤转移和治疗耐药性的综合方法:ECM 和皮肤生物力学与年龄相关变化的影响
- 批准号:
10333395 - 财政年份:2019
- 资助金额:
$ 51.71万 - 项目类别:
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin
黑色素瘤转移和治疗耐药性的综合方法:ECM 和皮肤生物力学与年龄相关变化的影响
- 批准号:
10158458 - 财政年份:2019
- 资助金额:
$ 51.71万 - 项目类别:
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin
黑色素瘤转移和治疗耐药性的综合方法:ECM 和皮肤生物力学与年龄相关变化的影响
- 批准号:
10574507 - 财政年份:2019
- 资助金额:
$ 51.71万 - 项目类别:
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin
黑色素瘤转移和治疗耐药性的综合方法:ECM 和皮肤生物力学与年龄相关变化的影响
- 批准号:
10524121 - 财政年份:2019
- 资助金额:
$ 51.71万 - 项目类别:
3D-adhesion stromagenesis in cancer permissiveness
癌症许可性中的 3D 粘附基质发生
- 批准号:
7142995 - 财政年份:2006
- 资助金额:
$ 51.71万 - 项目类别:
3D-Adhesion Stromagenesis in Cancer Permissiveness
癌症宽容度中的 3D 粘附基质发生
- 批准号:
8292558 - 财政年份:2006
- 资助金额:
$ 51.71万 - 项目类别:
相似国自然基金
肌动蛋白结合蛋白Xirp2介导基质刚度诱导心肌细胞肥大的力学生物学机制
- 批准号:12372314
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
肌动蛋白结合蛋白ANLN在胆汁淤积性肝损伤后肝再生过程中的作用及机制研究
- 批准号:82370648
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
转录因子Pax5调控肌动蛋白结合蛋白诱导线粒体凋亡在神经管畸形发生过程中的作用机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肌动蛋白结合蛋白2降调通过Rap1信号通路参与子痫前期发病的机制研究
- 批准号:82171676
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
肌动蛋白结合蛋白2降调通过Rap1信号通路参与子痫前期发病的机制研究
- 批准号:
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
相似海外基金
Molecular Determinants of Kidney Podocyte Architecture in Health, Injury, and Recovery
健康、损伤和恢复中肾足细胞结构的分子决定因素
- 批准号:
10659239 - 财政年份:2022
- 资助金额:
$ 51.71万 - 项目类别:
Molecular and cellular mechanisms of the actin cytoskeleton organization and function
肌动蛋白细胞骨架组织和功能的分子和细胞机制
- 批准号:
10419950 - 财政年份:2022
- 资助金额:
$ 51.71万 - 项目类别:
Discovery of Cell-based Chemical Probes Targeting Aberrant Angiogenesis in the Eye
发现针对眼部异常血管生成的基于细胞的化学探针
- 批准号:
10453044 - 财政年份:2022
- 资助金额:
$ 51.71万 - 项目类别:
Molecular and cellular mechanisms of the actin cytoskeleton organization and function
肌动蛋白细胞骨架组织和功能的分子和细胞机制
- 批准号:
10797753 - 财政年份:2022
- 资助金额:
$ 51.71万 - 项目类别:
Pancreatic cancer-associated fibroblasts: function, detection, and regulation
胰腺癌相关成纤维细胞:功能、检测和调节
- 批准号:
10625325 - 财政年份:2022
- 资助金额:
$ 51.71万 - 项目类别: